Optovue was the first to release 3D OCT Angiography (OCTA), AngioVueHD and AngioAnalytics upgrades for their Avanti OCT model; delivering high definition imaging of retinal and choroidal micro vasculature at all plane depths, and analysis of retinal blood flow.
OCTA is non-invasive and may be used for routine screening and management of retinal, choroidal and optic disc vascular disorders. AngioVueHD imaging is useful for diagnosing retinal vascular disorders, including diabetic retinopathy, showing capillary dropout and micro aneurysms at the superficial and deep plexus layers, and finely displaying retinal and choroidal neovascularization.
AngioAnalytics features include quantification of non-flow and quantification of flow in the inner and retinal layers respectively; vessel density mapping; enlargement of the foveal avascular zone (FAZ); A-circularity index; trend reports for vessel density; FAZ area and perimeter; and AngioAnalytics of the optic nerve head.
Contact: BOC Instruments (AUS) 02 9643 7888